e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Pathogenesis of diffuse parenchymal lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Familial interstitial lung disease and ABCA3 gene Gly964Asp mutation
I. Campo, Z. Kadija, M. Zorzetto, F. Mariani, G. Schmitz, M. Griese, M. Luisetti (Italy; Regensburg, Munich, Germany)
Source:
Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Session:
Pathogenesis of diffuse parenchymal lung disease
Session type:
Thematic Poster Session
Number:
4184
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Campo, Z. Kadija, M. Zorzetto, F. Mariani, G. Schmitz, M. Griese, M. Luisetti (Italy; Regensburg, Munich, Germany). Familial interstitial lung disease and ABCA3 gene Gly964Asp mutation. Eur Respir J 2010; 36: Suppl. 54, 4184
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion: respiratory care for newborns in resource-limited settings
Panel discussion on genetics in pulmonary fibrosis
Related content which might interest you:
Progressive lung disease caused by ABCA3 mutation
Source: Virtual Congress 2020 – From the bronchoscope to the clinic: paediatric bronchology at a glance
Year: 2020
Pediatric interstitial lung disease caused by a novel ABCA3 mutation: ABCA3
G964A
Source: Annual Congress 2009 - Cell biology of lung disease
Year: 2009
Classification of different ABCA3 mutations causing interstitial lung disease
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Combined pulmonary fibrosis and emphysema syndrome associated with ABCA3 mutations
Source: Eur Respir J 2014; 43: 638-641
Year: 2013
Intersitial lung disease in chlidren with mutation in the SFTPC and SFPTB gene: A two case report
Source: International Congress 2017 – Pulmonary infection and inflammation
Year: 2017
Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis
Source: Eur Respir J 2015; 46: 474-485
Year: 2015
Mutations in SFTPC, SFTPA2 and TERT explain 60% of familial pulmonary fibrosis and correlate to specific disease phenotypes
Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Year: 2011
Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene
Source: Eur Respir J 2004; 24: 30-39
Year: 2004
SFTPA mutations in interstitial lung disease (ILD) and lung cancer
Source: International Congress 2017 – Rare diseases
Year: 2017
Pulmonary fibrosis in non-mutation carriers of families with short telomere syndrome gene mutations.
Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis
Year: 2021
Germline SFTPA1 mutation in familial idiopathic interstitial pneumonia and lung cancer
Source: International Congress 2016 – IPF pathogenesis
Year: 2016
Interstitial lung disease in a child heterozygous for the 1549C?GAA (121ins2) mutation of surfactant protein B
Source: Eur Respir J 2011; 38: 985-987
Year: 2011
Functional assessment and phenotypic heterogeneity of
SFTPA1
and
SFTPA2
mutations in interstitial lung diseases and lung cancer
Source: Eur Respir J, 56 (6) 2002806; 10.1183/13993003.02806-2020
Year: 2020
Sftpc mutations are a common cause of adult familial idiopathic interstitial pneumonia
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009
First heterozygous
NOP10
mutation in familial pulmonary fibrosis
Source: Eur Respir J, 55 (6) 1902465; 10.1183/13993003.02465-2019
Year: 2020
Diffuse lung disease and pulmonary hypertension related to TBX4 mutation in 5 children
Source: International Congress 2019 – A mixture of rare lung diseases
Year: 2019
Hereditary pulmonary alveolar proteinosis caused by recessive CSF2RB mutations
Source: Eur Respir J 2011; 37: 201-204
Year: 2011
Cellular consequences of uncharacterized surfactant protein-A2 (SFTPA2)-gene mutations associated with familial IPF and lung cancer
Source: International Congress 2019 – Pathogenesis and prognosis of interstitial lung disease of known origin
Year: 2019
Genetics variants in familial interstitial pneumonia and progressive fibrosing interstitial lung disease (PF-ILD)
Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis
Year: 2021
Phenotype heterogeneity in a familial "brain lung thyroid syndrome" related to a novel NKX-2.1 mutation
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept